Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50,013,453
-
Total 13F shares
-
707,048
-
Share change
-
-1,239,077
-
Total reported value
-
$777,000
-
Price per share
-
$1.10
-
Number of holders
-
8
-
Value change
-
-$2,285,875
-
Number of buys
-
4
-
Number of sells
-
8
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q1 2022
As of 31 Mar 2022,
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
707,048 shares.
The largest 8 holders included
Stonepine Capital Management, LLC, VANGUARD GROUP INC, DRIVE WEALTH MANAGEMENT, LLC, Intersect Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, and NORTHERN TRUST CORP.
This page lists
8
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.